IRIS UniCatt

Lopetuso, Loris Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.941
AS - Asia 4.853
EU - Europa 4.309
SA - Sud America 1.027
Continente sconosciuto - Info sul continente non disponibili 281
AF - Africa 132
OC - Oceania 7
Totale 19.550
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.556
SG - Singapore 2.235
CN - Cina 1.090
IT - Italia 1.070
BR - Brasile 811
SE - Svezia 779
DE - Germania 738
FR - Francia 454
VN - Vietnam 422
GB - Regno Unito 251
IE - Irlanda 218
CA - Canada 177
IN - India 165
FI - Finlandia 155
ID - Indonesia 145
UA - Ucraina 139
JP - Giappone 136
BD - Bangladesh 135
PL - Polonia 125
HK - Hong Kong 118
RU - Federazione Russa 115
AR - Argentina 81
MX - Messico 81
TR - Turchia 75
KR - Corea 47
NL - Olanda 47
ZA - Sudafrica 45
ES - Italia 40
IQ - Iraq 40
EC - Ecuador 37
BE - Belgio 35
JM - Giamaica 30
IR - Iran 28
CO - Colombia 27
PK - Pakistan 22
SA - Arabia Saudita 22
VE - Venezuela 21
IL - Israele 20
UZ - Uzbekistan 19
EG - Egitto 17
LT - Lituania 17
PH - Filippine 17
CL - Cile 15
CR - Costa Rica 15
AT - Austria 14
HN - Honduras 14
NP - Nepal 14
AZ - Azerbaigian 13
CZ - Repubblica Ceca 13
AE - Emirati Arabi Uniti 12
MY - Malesia 12
PE - Perù 12
RO - Romania 12
TT - Trinidad e Tobago 12
KE - Kenya 11
NI - Nicaragua 11
PY - Paraguay 11
CI - Costa d'Avorio 10
EU - Europa 10
JO - Giordania 10
MA - Marocco 10
SV - El Salvador 10
TN - Tunisia 9
CH - Svizzera 8
RS - Serbia 8
SC - Seychelles 8
BG - Bulgaria 7
DZ - Algeria 7
GR - Grecia 7
OM - Oman 7
AL - Albania 6
CW - ???statistics.table.value.countryCode.CW??? 6
GT - Guatemala 6
TH - Thailandia 6
TW - Taiwan 6
UY - Uruguay 6
AU - Australia 5
BH - Bahrain 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
GP - Guadalupe 5
HR - Croazia 5
HU - Ungheria 5
KZ - Kazakistan 5
LV - Lettonia 5
PR - Porto Rico 5
EE - Estonia 4
ET - Etiopia 4
NO - Norvegia 4
PS - Palestinian Territory 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BO - Bolivia 3
KG - Kirghizistan 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
SI - Slovenia 3
AM - Armenia 2
Totale 19.236
Salva come PNG Salva come JPEG
Città #
Singapore 1.278
Ashburn 1.005
Chandler 819
San Jose 808
Beijing 300
New York 238
Los Angeles 228
Dublin 207
Council Bluffs 180
Rome 161
Dallas 148
Ho Chi Minh City 141
Lauterbourg 127
Jakarta 124
Tokyo 123
Cattolica 114
Hanoi 114
Boston 111
Milan 108
Jacksonville 107
Hong Kong 100
North Bergen 97
The Dalles 97
Ann Arbor 93
Warsaw 92
Santa Clara 91
San Mateo 90
Hefei 88
Wilmington 88
Frankfurt am Main 87
Munich 86
São Paulo 78
Princeton 74
Houston 73
Fairfield 71
Nanjing 70
Chicago 69
Helsinki 69
Atlanta 63
Marseille 61
Seattle 58
Woodbridge 54
Moscow 52
Phoenix 52
Dearborn 50
Hangzhou 47
Boardman 46
London 43
Redwood City 42
Montreal 41
Brooklyn 40
San Francisco 40
Buffalo 39
Izmir 39
Denver 36
Nuremberg 35
Seoul 35
Orem 34
Shanghai 34
Stockholm 34
St Louis 32
Brussels 30
Chennai 30
Guangzhou 30
Toronto 29
Lawrence 28
Turku 28
Bremen 27
Johannesburg 27
Lappeenranta 27
Paris 27
Augusta 25
Da Nang 24
Philadelphia 24
Rio de Janeiro 24
Memphis 23
Shenyang 23
Tianjin 23
Kent 22
Lancaster 22
Poplar 22
Pune 22
Nürnberg 21
Redmond 21
Florence 20
Manchester 20
Mexico City 20
Andover 19
Belo Horizonte 19
Haiphong 19
Nanchang 19
Amsterdam 18
Norwalk 18
Baghdad 17
Cambridge 17
Austin 16
Charlotte 16
Hyderabad 16
Jiaxing 16
Kraków 16
Totale 9.826
Salva come PNG Salva come JPEG
Nome #
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 401
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. 377
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 333
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 305
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 289
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 275
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 253
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 231
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 229
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 222
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 217
The gut barrier: new acquisitions and therapeutic approaches 215
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 211
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 206
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 196
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 194
13C-octanoic acid breath test to study gastric emptying time 194
Federated learning in inflammatory bowel disease: The future of privacy-preserving Artificial Intelligence 192
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 188
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 187
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 185
Actinobacteria: A relevant minority for the maintenance of gut homeostasis 183
The gastrointestinal microbiome - functional interference between stomach and intestine 173
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 172
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 171
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 170
Digital integration between hospitals and local health authorities for enhanced vaccination coverage among frail patients: the CareVax study protocol 170
Development and validation of predictive assessment of complicated diverticulitis score 168
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 167
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 167
The use of probiotics in different phases of diverticular disease 163
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 162
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 161
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 160
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 160
Bacillus clausii and gut homeostasis: state of the art and future perspectives 159
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools 158
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 157
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 155
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 155
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 153
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 152
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 152
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 149
Endoscopic Management of Strictures in Crohn’s Disease: An Unsolved Case 148
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 148
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 147
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 147
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 146
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 146
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 146
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 146
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 143
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis 142
Commensal Clostridia: leading players in the maintenance of gut homeostasis 142
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 140
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 139
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 138
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 135
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 134
Gut microbiota and inflammatory bowel disease: an update 134
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 134
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 134
Microbiota Composition in Diverticular Disease: Implications for Therapy 133
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 132
Can we predict the efficacy of anti-TNF-α agents? 132
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 132
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 131
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 128
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 126
Considering gut microbiota disturbance in the management of Helicobacter pylori infection 125
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 125
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 124
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals 124
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 124
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 123
Radiomics could predict surgery at 10 years in Crohn's disease 121
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 121
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 120
Microbiota Composition in Diverticular Disease: Implications for Therapy 119
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists 119
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 119
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 117
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 116
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 113
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 113
Psychopharmacological Therapy Positively Modulates Disease Activity in Inflammatory Bowel Disease: A Systematic Review 112
Vascular complications in hospitalized patients with inflammatory bowel disease and acute gastroenteritis and colitis: A propensity score-matched study 110
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update 110
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 110
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 110
Diet and Microbiota Modulation for Chronic Pouchitis: Evidence, Challenges, and Opportunities 109
[Ulcerative colitis] 109
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches 108
Coeliac disease under a microscope: Histological diagnostic features and confounding factors 107
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 107
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 107
Driving scientific progress and shaping the future of gastroenterology: a new start for our Journal, between innovation, growth and multidisciplinarity 106
Gut Virome and Inflammatory Bowel Disease 105
Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases 103
Totale 15.876
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.007
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022732 0 0 0 0 70 25 12 135 48 94 180 168
2022/20232.198 311 305 164 346 135 248 103 176 239 35 75 61
2023/20241.220 76 313 54 74 42 171 79 49 54 43 123 142
2024/20252.476 59 74 206 61 179 84 118 103 328 292 518 454
2025/20266.923 985 194 388 864 1.232 364 1.093 345 501 470 234 253
2026/20273.404 324 1.022 604 1.244 210 0 0 0 0 0 0 0
Totale 19.550